Recent Quarter Total Invested
$3.54 B
Recent Quarter Institutional Ownership Percentage
110.49%
Total Invested of Last Quarter
$2.98 B
Ownership Percentage of Last Quarter
115.23%
Rhythm Pharmaceuticals, Inc. Major Shareholders & Ownership History
Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
---|---|---|---|---|---|
PRIMECAP MANAGEMENT CO/CA/ | 11/08/2024 | 7.22 M | $378.09 M | -1.31% | 11.79% |
BLACKROCK FUNDING, INC. /DE | 11/13/2024 | 6.89 M | $360.93 M | 100.00% | 11.25% |
BAKER BROS. ADVISORS LP | 11/14/2024 | 6.40 M | $335.21 M | 0.00% | 10.45% |
RA CAPITAL MANAGEMENT, L.P. | 11/14/2024 | 6.08 M | $318.76 M | 0.00% | 9.94% |
GOLDMAN SACHS GROUP INC | 11/14/2024 | 3.88 M | $203.26 M | -26.64% | 6.34% |
PERCEPTIVE ADVISORS LLC | 11/14/2024 | 3.56 M | $186.52 M | 3.30% | 5.82% |
NEA MANAGEMENT COMPANY, LLC | 11/14/2024 | 2.91 M | $152.45 M | 0.00% | 4.75% |
FRAZIER LIFE SCIENCES MANAGEMENT, L.P. | 11/15/2024 | 2.42 M | $126.62 M | 1.93% | 3.95% |
STATE STREET CORP | 11/14/2024 | 1.99 M | $104.42 M | -0.53% | 3.26% |
POLAR CAPITAL HOLDINGS PLC | 11/14/2024 | 1.50 M | $78.59 M | 0.00% | 2.45% |
DRIEHAUS CAPITAL MANAGEMENT LLC | 11/14/2024 | 1.30 M | $68.08 M | 9.91% | 2.12% |
GEODE CAPITAL MANAGEMENT, LLC | 11/12/2024 | 1.26 M | $65.82 M | 0.28% | 2.05% |
ROCK SPRINGS CAPITAL MANAGEMENT LP | 11/14/2024 | 1.23 M | $64.34 M | -4.09% | 2.01% |
ALKEON CAPITAL MANAGEMENT LLC | 11/14/2024 | 1.17 M | $61.18 M | 16.77% | 1.91% |
HEALTHCARE OF ONTARIO PENSION PLAN TRUST FUND | 11/13/2024 | 1.11 M | $58.21 M | 14.87% | 1.81% |
CHECKPOINT CAPITAL L.P. | 11/14/2024 | 663,381 | $34.75 M | -28.06% | 1.08% |
COMMODORE CAPITAL LP | 11/14/2024 | 650,000 | $34.05 M | -46.94% | 1.06% |
LOOMIS SAYLES & CO L P | 11/13/2024 | 636,628 | $33.35 M | 100.00% | 1.04% |
HOOD RIVER CAPITAL MANAGEMENT LLC | 11/14/2024 | 614,598 | $32.20 M | 100.00% | 1.00% |
JANUS HENDERSON GROUP PLC | 11/14/2024 | 598,122 | $31.34 M | 0.75% | 0.98% |
PRICE T ROWE ASSOCIATES INC /MD/ | 11/14/2024 | 550,530 | $28.84 M | 4.68% | 0.90% |
OPALEYE MANAGEMENT INC. | 11/14/2024 | 500,000 | $26.20 M | -2.91% | 0.82% |
MORGAN STANLEY | 11/14/2024 | 464,604 | $24.34 M | -2.32% | 0.76% |
ORBIMED ADVISORS LLC | 11/14/2024 | 435,900 | $22.84 M | -38.16% | 0.71% |
CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 11/12/2024 | 433,866 | $22.73 M | 1.38% | 0.71% |
MARSHALL WACE, LLP | 11/14/2024 | 406,615 | $21.30 M | 280.69% | 0.66% |
CORMORANT ASSET MANAGEMENT, LP | 11/14/2024 | 400,000 | $20.96 M | -15.79% | 0.65% |
CANDRIAM S.C.A. | 11/13/2024 | 395,377 | $20.71 M | 45.68% | 0.65% |
VOLORIDGE INVESTMENT MANAGEMENT, LLC | 11/14/2024 | 353,323 | $18.51 M | -23.55% | 0.58% |
NATIONAL BANK OF CANADA /FI/ | 11/15/2024 | 341,507 | $17.89 M | -15.52% | 0.56% |
PICTET ASSET MANAGEMENT HOLDING SA | 11/12/2024 | 329,339 | $17.25 M | -58.92% | 0.54% |
SOFINNOVA INVESTMENTS, INC. | 11/13/2024 | 276,678 | $14.50 B | 100.00% | 0.45% |
INVESCO LTD. | 11/12/2024 | 264,417 | $13.85 M | -4.44% | 0.43% |
FRANKLIN RESOURCES INC | 11/12/2024 | 259,416 | $13.03 M | 11.49% | 0.42% |
SILVERARC CAPITAL MANAGEMENT, LLC | 11/14/2024 | 255,578 | $13.39 M | 38.40% | 0.42% |
SUSQUEHANNA INTERNATIONAL GROUP, LLP | 11/14/2024 | 232,600 | $12.19 M | 148.77% | 0.38% |
CAPTION MANAGEMENT, LLC | 11/14/2024 | 190,800 | $10.00 M | 281.60% | 0.31% |
SAMSARA BIOCAPITAL, LLC | 11/14/2024 | 172,647 | $9.04 M | 0.00% | 0.28% |
BANK OF NEW YORK MELLON CORP | 11/12/2024 | 148,926 | $7.80 M | -22.38% | 0.24% |
NUVEEN ASSET MANAGEMENT, LLC | 11/14/2024 | 147,875 | $7.75 M | -0.83% | 0.24% |
WOODLINE PARTNERS LP | 11/14/2024 | 143,823 | $7.53 M | 225.05% | 0.23% |
GREAT LAKES ADVISORS, LLC | 11/04/2024 | 136,950 | $7.17 M | 100.00% | 0.22% |
ABRDN PLC | 10/25/2024 | 112,804 | $5.91 M | 0.00% | 0.18% |
BARCLAYS PLC | 11/19/2024 | 106,397 | $5.57 M | 98.39% | 0.17% |
BANK OF AMERICA CORP /DE/ | 11/14/2024 | 106,250 | $5.57 M | 15.44% | 0.17% |
VOYA INVESTMENT MANAGEMENT LLC | 11/14/2024 | 102,832 | $5.39 M | 171.96% | 0.17% |
CITADEL ADVISORS LLC | 11/14/2024 | 102,778 | $5.38 M | 100.00% | 0.17% |
LORD, ABBETT & CO. LLC | 11/14/2024 | 102,646 | $5.38 M | 0.05% | 0.17% |
HENNION & WALSH ASSET MANAGEMENT, INC. | 10/22/2024 | 100,961 | $5.29 M | 4.76% | 0.16% |
SWISS NATIONAL BANK | 11/07/2024 | 89,300 | $4.68 M | 0.68% | 0.15% |
Rhythm Pharmaceuticals, Inc.institutional Ownership - Frequently Asked Questions
-
Who are the largest shareholders of RYTM shares?
During the previous two years, 194 institutional investors and hedge funds held shares of Rhythm Pharmaceuticals, Inc.. The most heavily invested institutionals were:
PRIMECAP MANAGEMENT CO/CA/: 7.22 M
BlackRock Funding, Inc. /DE: 6.89 M
BAKER BROS. ADVISORS LP: 6.4 M
RA CAPITAL MANAGEMENT, L.P.: 6.08 M
GOLDMAN SACHS GROUP INC: 3.88 M
PERCEPTIVE ADVISORS LLC: 3.56 M
-
What percentage of Rhythm Pharmaceuticals, Inc. stock is owned by institutional investors?
110.49% of Rhythm Pharmaceuticals, Inc. stock is owned by institutional investors.
-
How much institutional buying is happening at RYTM ?
Institutional investors have bought a total of 68.45 M shares in the last 24 months. This purchase volume represents approximately $4.09 B in transactions.